Citadel Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Buy
30,514
+4,747
+18% +$69.4K ﹤0.01% 9520
2025
Q4
$343K Buy
25,767
+13,854
+116% +$202K ﹤0.01% 9846
2025
Q3
$188K Sell
11,913
-25,498
-68% -$420K ﹤0.01% 11323
2025
Q2
$563K Buy
37,411
+32,306
+633% +$472K ﹤0.01% 8362
2025
Q1
$76.8K Sell
5,105
-31,352
-86% -$464K ﹤0.01% 11809
2024
Q4
$525K Buy
36,457
+18,568
+104% +$332K ﹤0.01% 8444
2024
Q3
$349K Sell
17,889
-5,727
-24% -$104K ﹤0.01% 9009
2024
Q2
$404K Buy
23,616
+16,511
+232% +$305K ﹤0.01% 8495
2024
Q1
$119K Sell
7,105
-44,121
-86% -$669K ﹤0.01% 11110
2023
Q4
$928K Buy
51,226
+44,006
+610% +$800K ﹤0.01% 6824
2023
Q3
$122K Sell
7,220
-18,959
-72% -$272K ﹤0.01% 10640
2023
Q2
$314K Sell
26,179
-21,930
-46% -$299K ﹤0.01% 8948
2023
Q1
$626K Sell
48,109
-168,804
-78% -$2.77M ﹤0.01% 7834
2022
Q4
$3.21M Buy
216,913
+147,570
+213% +$1.61M ﹤0.01% 4646
2022
Q3
$614K Buy
+69,343
New +$873K ﹤0.01% 8016
2022
Q1
Sell
-14,790
Closed -$519K 13985
2021
Q4
$519K Sell
14,790
-12,158
-45% -$395K ﹤0.01% 9607
2021
Q3
$987K Buy
26,948
+14,330
+114% +$564K ﹤0.01% 8189
2021
Q2
$496K Sell
12,618
-15,874
-56% -$458K ﹤0.01% 10082
2021
Q1
$805K Buy
+28,492
New +$909K ﹤0.01% 8625
2020
Q3
Sell
-39,812
Closed -$1.1M 10321
2020
Q2
$1.1M Sell
39,812
-1,532
-4% -$33.2K ﹤0.01% 5669
2020
Q1
$738K Buy
41,344
+4,889
+13% +$118K ﹤0.01% 5839
2019
Q4
$914K Sell
36,455
-44,866
-55% -$982K ﹤0.01% 5761
2019
Q3
$1.45M Sell
81,321
-25
-0% -$521 ﹤0.01% 4980
2019
Q2
$1.79M Buy
+81,346
New +$2.32M ﹤0.01% 4708
2018
Q3
Sell
-7,029
Closed -$212K 9406
2018
Q2
$212K Sell
7,029
-2,645
-27% -$84K ﹤0.01% 7797
2018
Q1
$286K Buy
+9,674
New +$344K ﹤0.01% 6821

Other funds holding HCM

Citadel Advisors's HCM Position: Q1 2026 in Review

Citadel Advisors increased its HUTCHMED (HCM) stake by 18% in Q1 2026, buying an estimated $69.4K and bringing the position to 30,514 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #9520.

Citadel Advisors first reported a position in HCM in Q1 2018 and has held it in 26 quarters since. The position peaked at $3.21M in Q4 2022. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Citadel Advisors held 30,514 shares of HUTCHMED worth $456K as of Q1 2026.
  • Citadel Advisors bought 4,747 HUTCHMED shares in Q1 2026, an estimated $69.4K.
  • HUTCHMED made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9520 holding.
  • Citadel Advisors first reported a position in HUTCHMED in Q1 2018 and has held it in 26 quarters since.
  • Citadel Advisors's HUTCHMED position peaked at $3.21M in Q4 2022.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.